RIVANNA® is elevating global standards of care through the development and commercialization of world-first imaging-based medical technologies, including BoneVision™ Multi-Probe Multi-Angle Image Acquisition, BoneEnhance® Multi-Frequency Image Reconstruction, and SpineNav3D™ AI-Enabled Spine Recognition. RIVANNA's complete clinician-assistance solutions improve decision-making, workflows, health outcomes, and patient satisfaction. Headquartered in Charlottesville, VA, RIVANNA is privately held and operates an FDA-registered and ISO 13485:2016 certified manufacturing facility. For more information, visit rivannamedical.com.
Investor insights
Funding rounds participated in
$2.9M sweet spot round size
Investor type
Basic info
Industry
Sectors
Date founded
2010
Funding rounds raised
Total raised
$2.9M
from 1 investors over 1 rounds
RIVANNA raised $2.9M on December 2, 2023
Investors: National Institutes of Health